Recombinant adeno viruses comprising an inserted gene encoding apolipoprotein and their use in gene therapy for dyslipoproteinemias
USRE38556E1 · kind E1 · reissue
2Cited by
3References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 4, 2000 |
| Grant date | Jul 13, 2004 |
| Priority date | — |
| Expiry date | Aug 4, 2020 |
Classification
- Technology area (CPC —)General
Abstract
The present invention concerns defective recombinant adenoviruses containing an inserted gene encoding apolipoproteins, pharmaceutical compositions comprising the adenovirus, and their use for the treatment or prevention of pathologies linked to dyslipoproteinemias.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.